Antiamnesic activity of metoclopramide, cisapride and SR-17 in the mouse passive avoidance test

Pharmacological Research

Volumn 36, Issue 1, 1997, Pages 59-67

  Galeotti, Nicoletta ^a   Ghelardini, Carla ^a,b   Teodori, Elisabetta ^a   Gualtieri, Fulvio ^a   Bartolini, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Department of Pharmacology ^*  (Italy)

Author keywords

5 HT3 antagonist; 5 HT4 agonist; Amnesia; Cisapride; Metoclopramide

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; ANTIEMETIC AGENT; CISAPRIDE; DICYCLOVERINE; METOCLOPRAMIDE; PHYSOSTIGMINE; PIRACETAM; SR 17; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEMORY; MOTOR COORDINATION; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; TRAINING;

EID: 0031192524     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0205     Document Type: Article

References (28)

1. 1. Linnik MD, Butler BT, Gaddis RR, Ahmed NK. Analysis of serotoninergic mechanisms underlying benzamide-induced gastroprokinesis. J Pharmacol Exp Ther 1991; 259: 501-7.
2. 2. Buchheit KH, Costall B, Eglen G, Gunning SJ, Naylor RJ, Richardson BP. 5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205-930 in the guinea pig leads to enhancement of contractions of stomach muscle strips by electrical field stimulation and facilitation of gastric emptying in vivo. J Pharm Pharmacol 1985; 37: 664-7.
3. 3. Nakayama ST, Neya T, Yamasato T, Takaki M, Itano N. Effects of cisapride on the motility of digestive tract in dogs and guinea pigs. Jap J Smooth Muscle Res 1985; 21: 1-9.
4. 4. Schuurkes JAJ, Van Nueten JM, Van Daele PGH, Reyntjens AJ, Janssen PA. Motor stimulating effect of cisapride on isolated gastrointestinal preparations of the guinea-pig. J Pharmacol Exp Ther 1985; 234: 775-83.
5. 5. Hasler WL, Heldsinger A, Owyang C. Cisapride acts on muscarinic (glandular M2) receptors to induce contraction of isolated gastric myocytes: mediation via a calcium-phosphoinositide pathway. J Pharmacol Exr Ther 1991; 259: 1294-300.
6. 6. Syed M, Tokuno J, Tomita T. Effects of cisapride on isolated guinea pig colon. Jpn J Pharmacol 1989; 51: 47-56.
7. 7. McKirdy HC, McKirdy ML, Marshall RW. Effect of cisapride on isolated muscle strips from human digestive tract. J Physiol 1990; 422: 88.
8. 8. Yoshida N, Karasawa T, Kadokawa T. Effect of metoclopramide and ranidine on acetylcholine release from isolated rat stomach. Arch Int Pharmacodyn 1988; 295: 245-56.
9. 4) receptors in guinea pig stomach: the effect of TKS 159, a novel agonist, on gastric motility and acetylcholine release. J Pharmacol Exp Ther 1996; 276: 989-95.
10. 4 agonist endowed with potent antinociceptive activity. Arzneim Forsch/Drug Res 1993; 43: 913-18.
11. 4 agonist. Proc III IUPHAR Salellite Meeting on Serotonin 1994: 57.
12. 3 receptor recognition sites in Alzheimer's disease. Neuroreport 1990; 1: 253-4.
13. 13. Jarvik ME, Kopp R. An improved one-trial passive avoidance learning situation. Psychol Rep 1967; 21: 221-4.
14. 14. Vaught J, Pelley K, Costa LG, Sether P, Enna SJ. A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen. Neuropharmacology 1985; 24: 211-6.
15. 15. Gouliaev AH, Senning A. Piracetam and other structurally related nootropics. Brain Res Rev 1994; 19: 180-222.
16. 16. Sarter M. Taking stock of cognition enhancer. Trends Pharmacol Sci 1991; 12: 456-61.
17. B receptor antagonist CGP 35348 in the mouse. Cogn Brain Res 1993; 1: 135-6.
18. 18. Galeotti N, Ghelardini C, Bartolini A. ICS-205930 and MDL-72222 protection of amnesia induced by scopolamine and hypoxia in mice. Pharmacol Res 1995; 31 (Suppl.): 260.
19. 4 agonists on scopolamine induced T-maze deficit. Proc Eur Neurosci Assoc 1995; 82.
20. 4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. J Pharmacol Exp Ther 1991; 257: 930-7.
21. 4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. Br J Pharmacol 1995; 114: 993-8.
22. 22. Ghelardini C, Meoni P, Galeotti N, Rizzi CA, Bartolini A. Effect of two benzamidazolone derivatives: BIMU1 and BIMU8 on a model of hypoxia induced amnesia in the mouse. Proc III IUPHAR Satellite Meeting on Serotonin 1994: 55.
23. 3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 1989; 338: 762-3.
24. 4 receptor stimulation facilitates acetylcholine release in frontal cortex. NeuroReport 1994; 5: 1230-2.
25. 25. Tonini M, Galligan JJ, North RA. Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea-pig ileum. Gastroenterology 1989; 96: 1257-64.
26. 4 receptor activation. Br J Pharmacol 1991; 102: 563-4.
27. 27. Sanger GJ. Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptor by BRL 24924: Potential clinical importance of BRL 24924. Br J Pharmacol 1987; 91: 77-87.
28. 28. Coyle MJ. A cholinergic hypothesis for Alzheimer's disease. In: Meyer L, Nordeberg GH, eds. Learning and memory molecular bases. London: Pergamon Press, 1995: 11-32.